MPO and idiopathic interstitial pneumonia: Only prospective longitudinal studies including a large number of patients may allow us to identify possible associated factors to the evolution towards vasculitis or other inflammatory rheumatic diseases and the prognostic role of anti-MPO antibodies in patients with idiopathic interstitial pneumonia.